STADA Start Company Products Product Selection Adverse drug reaction report Biosimilars Generics Quality at STADA Investor Relations Press Career German Faculty Login Quality at STADA Company PressContact Share page Print page Quality and responsibility towards all those who use our products and services is a fundamental component of our corporate strategy. We thereby take account of the great significance of quality in product safety in the health care market. Overall we align the quality policy throughout the Group to meet criteria that at least fulfill the strict legal requirements for pharmaceutical and health care products. Assessing the risks of newly arising, previously unknown side effects of active ingredients also plays an important role in the quality of pharmaceutical products. This risk remains low for most of our products as only long-standing and researched active pharmaceutical ingredients are generally used. Of course, we have nevertheless implemented within our operations all the standard graduated plan proceedings for recording or detecting such pharmaceutical product risks throughout the Group. Commodities In Process Control Control Finished Drugs Assembly and Batch Conformity Financial Reports Annual Reports and Interim Reports Products Curazink® Grippostad® Hedrin® Hoggar® Ladival® Locastad® Magnetrans® Multilind® Mobilat® STADA Diagnostik All Products Follow us STADA on Twitter STADA on Facebook STADA on YouTube STADA on XING STADA on LinkedIn Company Contact Contact Investor Relations Contact Press Newsletter Jobs Your journey to us Disclaimer Privacy Policy Imprint German Version Contact STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Phone 06101 603-0 Fax 06101 603-259 E-Mail: info@stada.de STADA is a Member of discover

STADA Start Company Products Investor Relations At a Glance News Stock Bonds Financial Publications Sustainability Calendar General Meeting Corporate Governance Contact Press Career German Faculty Login Financial Reports Additional financial information Company Profile Press Releases Contact IR Share page Print page Financial Reports Below you will find the current financial reports of STADA Arzneimittel AG. The reports can be downloaded in PDF format. Annual Report 2018 Download PDF Financial Statements 2018 Download PDF Financial Reports Annual Reports and Interim Reports Products Curazink® Grippostad® Hedrin® Hoggar® Ladival® Locastad® Magnetrans® Multilind® Mobilat® STADA Diagnostik All Products Follow us STADA on Twitter STADA on Facebook STADA on YouTube STADA on XING STADA on LinkedIn Company Contact Contact Investor Relations Contact Press Newsletter Jobs Your journey to us Disclaimer Privacy Policy Imprint German Version Contact STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Phone 06101 603-0 Fax 06101 603-259 E-Mail: info@stada.de STADA is a Member of discover